Literature DB >> 19017588

Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis.

Susan R Kahn1, Ian Shrier, Jim A Julian, Thierry Ducruet, Louise Arsenault, Marie-José Miron, Andre Roussin, Sylvie Desmarais, France Joyal, Jeannine Kassis, Susan Solymoss, Louis Desjardins, Donna L Lamping, Mira Johri, Jeffrey S Ginsberg.   

Abstract

BACKGROUND: The reason some patients with deep venous thrombosis (DVT) develop the postthrombotic syndrome is not well understood.
OBJECTIVE: To determine the frequency, time course, and predictors of the postthrombotic syndrome after acute DVT.
DESIGN: Prospective, multicenter cohort study.
SETTING: 8 Canadian hospital centers. PATIENTS: 387 outpatients and inpatients who received an objective diagnosis of acute symptomatic DVT were recruited from 2001 to 2004. MEASUREMENTS: Standardized assessments for the postthrombotic syndrome using the Villalta scale at 1, 4, 8, 12, and 24 months after enrollment. Mean postthrombotic score and severity category at each interval was calculated. Predictors of postthrombotic score profiles over time since diagnosis of DVT were identified by using linear mixed modeling.
RESULTS: At all study intervals, about 30% of patients had mild (score, 5 to 9), 10% had moderate (score, 10 to 14), and 3% had severe (score >14 or ulcer) postthrombotic syndrome. Greater postthrombotic severity category at the 1-month visit strongly predicted higher mean postthrombotic scores throughout 24 months of follow-up (1.97, 5.03, and 7.00 increase in Villalta score for mild, moderate, and severe 1-month severity categories, respectively, vs. none; P < 0.001). Additional predictors of higher scores over time were venous thrombosis of the common femoral or iliac vein (2.23 increase in score vs. distal [calf] venous thrombosis; P < 0.001), higher body mass index (0.14 increase in score per kg/m(2); P < 0.001), previous ipsilateral venous thrombosis (1.78 increase in score; P = 0.001), older age (0.30 increase in score per 10-year age increase; P = 0.011), and female sex (0.79 increase in score; P = 0.020). LIMITATIONS: Decisions to prescribe compression stockings were left to treating physicians rather than by protocol. Because international normalized ratio data were unavailable, the relationship between anticoagulation quality and Villalta scores could not be assessed.
CONCLUSION: The postthrombotic syndrome occurs frequently after DVT. Patients with extensive DVT and those with more severe postthrombotic manifestations 1 month after DVT have poorer long-term outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017588     DOI: 10.7326/0003-4819-149-10-200811180-00004

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  140 in total

1.  Elevated plasma gas6 levels are associated with venous thromboembolic disease.

Authors:  Mark D Blostein; Isabelle Rajotte; Deepa P Rao; Christina A Holcroft; Susan R Kahn
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

2.  Diagnosis and management of iliofemoral deep vein thrombosis: clinical practice guideline.

Authors:  David Liu; Erica Peterson; James Dooner; Mark Baerlocher; Leslie Zypchen; Joel Gagnon; Michael Delorme; Chad Kim Sing; Jason Wong; Randolph Guzman; Gavin Greenfield; Otto Moodley; Paul Yenson
Journal:  CMAJ       Date:  2015-09-28       Impact factor: 8.262

Review 3.  Deep vein thrombosis: pathogenesis, diagnosis, and medical management.

Authors:  Jonathan Stone; Patrick Hangge; Hassan Albadawi; Alex Wallace; Fadi Shamoun; M Grace Knuttien; Sailendra Naidu; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 4.  Animal models of venous thrombosis.

Authors:  Hassan Albadawi; Avery A Witting; Yash Pershad; Alex Wallace; Andrew R Fleck; Peter Hoang; Ali Khademhosseini; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 5.  Catheter-directed thrombolysis of deep vein thrombosis: literature review and practice considerations.

Authors:  Drew Fleck; Hassan Albadawi; Fadi Shamoun; Grace Knuttinen; Sailendra Naidu; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 6.  Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management.

Authors:  Paola Devis; M Grace Knuttinen
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 7.  Can thrombus age guide thrombolytic therapy?

Authors:  Christopher Czaplicki; Hassan Albadawi; Sasan Partovi; Ripal T Gandhi; Keith Quencer; Amy R Deipolyi; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

8.  Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis.

Authors:  Ariel Izcovich; Juan M Criniti; Federico Popoff; Liming Lu; Jiaming Wu; Walter Ageno; Daniel M Witt; Michael R Jaff; Sam Schulman; Veena Manja; Peter Verhamme; Gabriel Rada; Yuqing Zhang; Robby Nieuwlaat; Wojtek Wiercioch; Holger J Schünemann; Ignacio Neumann
Journal:  Blood Adv       Date:  2020-04-14

9.  Efficacy and Safety of Catheter-directed Thrombolysis in Preventing Post-thrombotic Syndrome: A Meta-analysis.

Authors:  Luai Alhazmi; Abdelmoneim Moustafa; Muhammad A Mangi; Ahmed Alamer; Ehab Eltahawy
Journal:  Cureus       Date:  2019-02-28

10.  The post-thrombotic syndrome: a 2012 therapeutic update.

Authors:  Jean-Philippe Galanaud; Susan R Kahn
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.